{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:45:56Z","timestamp":1792633556378,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007112","name":"Universityof CapeTown","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203135\/Z\/16\/Z"],"award-info":[{"award-number":["203135\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.intimp.2025.115047","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T23:04:51Z","timestamp":1750115091000},"page":"115047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Long-term omega-3 fatty acids modulate immune responses more effectively than ibuprofen in Mtb-infected mice: An in silico functional analysis approach"],"prefix":"10.1016","volume":"161","author":[{"given":"Simon\u00e9","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arista","family":"Nienaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank E.A.","family":"Hayford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin C.","family":"Dolman-Macleod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius M.","family":"Smuts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Malan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizelle","family":"Zandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115047_bb0005","first-page":"2024","author":"World Health Organization","year":"2024","journal-title":"Global TB Rep."},{"issue":"10052","key":"10.1016\/j.intimp.2025.115047_bb0010","first-page":"1","article-title":"A review of molecular investigations on traditional Chinese medicinal plant-based therapies in multidrug-resistant tuberculosis","volume":"13","author":"Singh","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115047_bb0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nrd4696","article-title":"Towards host-directed therapies for tuberculosis","volume":"14","author":"Zumla","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.intimp.2025.115047_bb0020","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4014\/jmb.1705.05032","article-title":"Host-directed therapeutics as a novel approach for tuberculosis treatment","volume":"27","author":"Kim","year":"2017","journal-title":"J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115047_bb0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000490478","article-title":"Host directed therapies for tuberculosis: futures strategies for an ancient disease","volume":"63","author":"Palucci","year":"2018","journal-title":"Chemotherapy"},{"key":"10.1016\/j.intimp.2025.115047_bb0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.micpath.2019.03.003","article-title":"Host-directed therapies to combat tuberculosis and associated non-communicable diseases","volume":"130","author":"Baindara","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2025.115047_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/854507","article-title":"Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers","volume":"2015","author":"Lyadova","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.intimp.2025.115047_bb0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-065X.2010.00994.x","article-title":"For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection","volume":"240","author":"Dorhoi","year":"2011","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2025.115047_bb0045","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.177.3.1416","article-title":"Cutting edge: IFN-\u03b3 regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial Infection1","volume":"177","author":"Cruz","year":"2006","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.intimp.2025.115047_bb0050","article-title":"Host-directed therapies in pulmonary tuberculosis: updates on anti-inflammatory drugs","volume":"9","author":"Cubillos-Angulo","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.intimp.2025.115047_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659943","article-title":"Longer-term Omega-3 LCPUFA more effective adjunct therapy for tuberculosis than ibuprofen in a C3HeB\/FeJ tuberculosis mouse model","volume":"12","author":"Hayford","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115047_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12325-019-01144-9","article-title":"Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review","volume":"37","author":"Varrassi","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.intimp.2025.115047_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.623941","article-title":"The manipulation of the lipid mediator metabolism as adjunct host-directed therapy in tuberculosis","volume":"12","author":"Nienaber","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115047_bb0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1017\/S0007114521001124","article-title":"Omega-3 long-chain polyunsaturated fatty acids promote antibacterial and inflammation-resolving effects in Mycobacterium tuberculosis-infected C3HeB\/FeJ mice, dependent on fatty acid status","volume":"127","author":"Nienaber","year":"2020","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.intimp.2025.115047_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.695452","article-title":"Adjunct n-3 long-chain polyunsaturated fatty acid treatment in tuberculosis reduces inflammation and improves Anemia of infection more in C3HeB\/FeJ mice with low n-3 fatty acid status than sufficient n-3 fatty acid status","volume":"8","author":"Hayford","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2025.115047_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2021.102304","article-title":"Beneficial effect of long-chain n-3 polyunsaturated fatty acid supplementation on tuberculosis in mice","volume":"170","author":"Nienaber","year":"2021","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.intimp.2025.115047_bb0085","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-065X.2008.00693.x","article-title":"Early T-cell responses in tuberculosis immunity","volume":"225","author":"Winslow","year":"2008","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2025.115047_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115047_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.806529","article-title":"T helper cell lineage-defining transcription factors: potent targets for specific GVHD therapy?","volume":"12","author":"Campe","year":"2022","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.intimp.2025.115047_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205028","article-title":"Effects of Omega-3 fatty acids on immune cells","volume":"20","author":"Guti\u00e9rrez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115047_bb0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1574-695X.1997.tb01046.x","article-title":"Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement","volume":"18","author":"Dlugovitzky","year":"1997","journal-title":"FEMS Immunology & Medical Microbiology"},{"issue":"24","key":"10.1016\/j.intimp.2025.115047_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034041","article-title":"Interleukin-4 expression is increased in patients with tuberculosis: a systematic review and meta-analysis","volume":"102","author":"He","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115047_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12931-017-0580-3","article-title":"Decreased T helper 17 cells in tuberculosis is associated with increased percentages of programmed death ligand 1, T helper 2 and regulatory T cells","volume":"18","author":"Shu","year":"2017","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115047_bb0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bjid.2016.10.011","article-title":"Imbalance of Th17 and Treg in peripheral blood mononuclear cells of active tuberculosis patients","volume":"21","author":"Luo","year":"2017","journal-title":"Braz. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2025.115047_bb0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/cmi.2017.128","article-title":"The crucial roles of Th17-related cytokines\/signal pathways in M. tuberculosis infection","volume":"15","author":"Shen","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115047_bb0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clim.2014.01.010","article-title":"Progression of clinical tuberculosis is associated with a Th2 immune response signature in combination with elevated levels of SOCS3","volume":"151","author":"Ashenafi","year":"2014","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115047_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tube.2007.07.003","article-title":"Gene expression profiles of bronchoalveolar cells in pulmonary TB","volume":"88","author":"Raju","year":"2008","journal-title":"Tuberculosis"},{"issue":"2","key":"10.1016\/j.intimp.2025.115047_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13085","article-title":"Immuno-genetic importance of Th17 in susceptibility to TB","volume":"94","author":"Rapolu","year":"2021","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115047_bb0145","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.4049\/jimmunol.1701424","article-title":"Th1, Th17, and Th1Th17 lymphocytes during tuberculosis: Th1 lymphocytes predominate and appear as low-differentiated CXCR3+CCR6+ cells in the blood and highly differentiated CXCR3+\/\u2212CCR6\u2212 cells in the lungs","volume":"200","author":"Nikitina","year":"2018","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115047_bb0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/09637486.2019.1646714","article-title":"Determining sample size adequacy for animal model studies in nutrition research: limits and ethical challenges of ordinary power calculation procedures","volume":"71","author":"Ricci","year":"2020","journal-title":"Int. J. Food Sci. Nutr."},{"issue":"7","key":"10.1016\/j.intimp.2025.115047_bb0155","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/biomedicines9070724","article-title":"Increased Th1 cells with disease resolution of active pulmonary tuberculosis in non-atopic patients","volume":"9","author":"Lo","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.intimp.2025.115047_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043073","article-title":"Relationship between hypoxic and immune pathways activation in the progression of neuroinflammation: role of HIF-1\u03b1 and Th17 cells","volume":"24","author":"Arias","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"44","key":"10.1016\/j.intimp.2025.115047_bb0165","doi-asserted-by":"crossref","first-page":"30190","DOI":"10.1074\/jbc.C114.598946","article-title":"Isoniazid induces apoptosis of activated CD4+ T cells: implications for post-therapy tuberculosis reactivation and reinfection","volume":"289","author":"Tousif","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2025.115047_bb0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.tube.2012.12.002","article-title":"Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB","volume":"93","author":"Mar\u00edn","year":"2013","journal-title":"Tuberculosis (Edinb.)"},{"issue":"4","key":"10.1016\/j.intimp.2025.115047_bb0175","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/eji.201243090","article-title":"Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease","volume":"43","author":"Perreau","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115047_bb0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/156652407780598557","article-title":"Th2 cytokines in susceptibility to tuberculosis","volume":"7","author":"Rook","year":"2007","journal-title":"Curr. Mol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115047_bb0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.immuni.2007.07.022","article-title":"T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis","volume":"27","author":"Harris","year":"2007","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2025.115047_bb0190","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/315325","article-title":"Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities","volume":"181","author":"van Crevel","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.intimp.2025.115047_bb0195","article-title":"Significant difference in Th1\/Th2 paradigm induced by tuberculosis-specific antigens between IGRA-positive and IGRA-negative patients","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115047_bb0200","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1038\/s41598-022-06685-8","article-title":"A meta-analysis of Th1 and Th2 cytokine profiles differentiating tuberculous from malignant pleural effusion","volume":"12","author":"Zeng","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.115047_bb0205","article-title":"Prevalence of multidrug-resistant tuberculosis and associated factors in Ethiopia: a systematic review","volume":"2018","author":"Asgedom","year":"2018","journal-title":"Journal of pathogens"},{"issue":"2","key":"10.1016\/j.intimp.2025.115047_bb0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/infdis\/jit152","article-title":"Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis","volume":"208","author":"Vilaplana","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.intimp.2025.115047_bb0215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12931-020-01488-9","article-title":"The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis","volume":"21","author":"Hayford","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2025.115047_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00772","article-title":"Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: a systematic review","volume":"8","author":"Kroesen","year":"2017","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115047_bb0225","first-page":"24","article-title":"Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults","volume":"18","author":"Marcum","year":"2010","journal-title":"Ann Longterm Care"},{"issue":"1","key":"10.1016\/j.intimp.2025.115047_bb0230","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2008.08.002","article-title":"Compartmentalized bronchoalveolar IFN-\u03b3 and IL-12 response in human pulmonary tuberculosis","volume":"89","author":"Herrera","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.intimp.2025.115047_bb0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/A:1020604331886","article-title":"Cytokine polarization in miliary and pleural tuberculosis","volume":"22","author":"Sharma","year":"2002","journal-title":"J. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115047_bb0240","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.4049\/jimmunol.173.10.6151","article-title":"Dietary docosahexaenoic acid suppresses T cell protein kinase C\u03b8 lipid raft recruitment and IL-2 production","volume":"173","author":"Fan","year":"2004","journal-title":"The Journal of Immunology"},{"issue":"12","key":"10.1016\/j.intimp.2025.115047_bb0245","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1194\/jlr.M900101-JLR200","article-title":"Docosahexaenoic acid reduces suppressive and migratory functions of CD4CD25 regulatory T-cells","volume":"50","author":"Yessoufou","year":"2009","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115047_bb0250","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2249.2001.01627.x","article-title":"Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation","volume":"125","author":"Arrington","year":"2001","journal-title":"Clinical & Experimental Immunology"},{"key":"10.1016\/j.intimp.2025.115047_bb0255","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s42003-019-0530-3","article-title":"Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice","volume":"2","author":"Mortensen","year":"2019","journal-title":"Commun Biol"},{"issue":"10","key":"10.1016\/j.intimp.2025.115047_bb0260","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.humimm.2010.07.009","article-title":"Toll-like receptors, tumor necrosis factor\u2013\u03b1, and interleukin-10 gene polymorphisms in risk of pulmonary tuberculosis and disease severity","volume":"71","author":"Ma","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2025.115047_bb0265","first-page":"484","article-title":"Mycobacterium tuberculosis infection: participation of TH1, TH2, TH17 and regulatory T cells in the immune response","author":"Soto","year":"2018","journal-title":"Acta Med. Iran."},{"issue":"2","key":"10.1016\/j.intimp.2025.115047_bb0270","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/jit153","article-title":"Nonsteroidal antiinflammatory drugs for adjunctive tuberculosis treatment","volume":"208","author":"Ivanyi","year":"2013","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.intimp.2025.115047_bb0275","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/infdis\/jit476","article-title":"Low-dose aspirin and ibuprofen\u2019s sterilizing effects on Mycobacterium tuberculosis suggest safe new adjuvant therapies for tuberculosis","volume":"208","author":"Eisen","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.intimp.2025.115047_bb0280","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3389\/fimmu.2020.00962","article-title":"Neutrophils in tuberculosis-associated inflammation and lung pathology","volume":"11","author":"Muefong","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115047_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100428","article-title":"Eicosapentaenoic acid reduces the proportion of IL-17A-producing T cells in a 3D psoriatic skin model","volume":"64","author":"Morin","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.intimp.2025.115047_bb0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cyto.2016.06.002","article-title":"Effects of omega-3 fatty acids on serum levels of T-helper cytokines in children with asthma","volume":"85","author":"Farjadian","year":"2016","journal-title":"Cytokine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T19:50:16Z","timestamp":1775764216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925010379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":58,"alternative-id":["S1567576925010379"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115047","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term omega-3 fatty acids modulate immune responses more effectively than ibuprofen in Mtb-infected mice: An in silico functional analysis approach","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115047"}}